Insmed to Present Multiple Abstracts on Treprostinil Palmitil Inhalation Powder (TPIP) at Pulmonary Vascular Research Institute (PVRI) 2026 CongressPRNewsWire • 01/28/26
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSMPRNewsWire • 01/22/26
Insmed Incorporated (INSM) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/13/26
Insmed Maps Aggressive 2026 As Newly Approved Lung Disease Drug Gains Traction, Pipeline AdvancesBenzinga • 01/09/26
Insmed Provides Business Update at 44th Annual J.P. Morgan Healthcare ConferencePRNewsWire • 01/09/26
INSM Investors Have Opportunity to Join Insmed Incorporated Fraud Investigation with the Schall Law FirmBusiness Wire • 12/30/25
4 Drug, Biotech Stocks Rising More Than 50% in 2025 With Room to GrowZacks Investment Research • 12/24/25
INSM Stock Plummets on Sinus Study Failure, Adds New Pipeline AssetZacks Investment Research • 12/18/25
Birkenstock, Insmed And Other Big Stocks Moving Lower In Thursday's Pre-Market SessionBenzinga • 12/18/25
The 'Worst-Case Scenario' — Why Insmed Just Reversed Its 181% Six-Month SprintInvestors Business Daily • 12/18/25
Billionaire Stanley Druckenmiller is Betting $1.2 Billion in These 3 Stocks24/7 Wall Street • 12/11/25
Insmed Incorporated (INSM) Presents at Evercore 8th Annual Healthcare Conference TranscriptSeeking Alpha • 12/02/25
30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech StocksThe Motley Fool • 11/30/25